What Climb Bio Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 3 |
| Sells | 1 | 6 |
| Total trades | 5 | 15 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 70,000 | 460,422 |
| Disposed | 100,000 | 20,720,902 |
| Net activity | −30,000 | −20,260,480 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ra Capital MANAGEMENT, L.p. | Director | Sep 28 | Exercise / conversion · M | +40,000 | $1.29 | +$51.6K | 70,000 |
| Ra Capital MANAGEMENT, L.p. | Director | Sep 28 | Exercise / conversion · M | +10,000 | $7.89 | +$78.9K | 30,000 |
| Ra Capital MANAGEMENT, L.p. | Director | Sep 28 | Exercise / conversion · M | +10,000 | $3.00 | +$30K | 20,000 |
| Ra Capital MANAGEMENT, L.p. | Director | Sep 28 | Exercise / conversion · M | +10,000 | $3.46 | +$34.6K | 10,000 |
| Thomas Stephen Basil | Director | Sep 15 | Open-market sale · S | −100,000 | $13.67 | −$1.37M | 467,969 |
| Brennan Aoife | President and CEO | Jun 29 | Open-market sale · S | −30,902 | $13.17 | −$407K | 87,731 |
| Brennan Aoife | President and CEO | Jun 27 | Exercise / conversion · M | +68,750 | — | — | 118,633 |
| Thomas Stephen Basil | Director | Feb 26 | Open-market sale · S | −16,313 | $7.01 | −$114K | 154,657 |
| Thomas Stephen Basil | Director | Feb 25 | Open-market sale · S | −33,687 | $7.00 | −$236K | 170,970 |
| Thomas Stephen Basil | Director | Feb 13 | Open-market sale · S | −10,000 | $5.81 | −$58.1K | 204,657 |
| Thomas Stephen Basil | Director | Feb 12 | Open-market sale · S | −90,000 | $5.23 | −$471K | 214,657 |
| Ra Capital MANAGEMENT, L.p. | Director | Jan 05 | Open-market buy · P | +7,111 | $3.50 | +$24.9K | 3,403,429 |
| Ra Capital MANAGEMENT, L.p. | Director | Dec 12 | Open-market buy · P | +101,462 | $2.86 | +$290K | 3,396,318 |
| Ra Capital MANAGEMENT, L.p. | Director | Dec 11 | Open-market buy · P | +213,099 | $2.18 | +$465K | 3,294,856 |
| Ra Capital MANAGEMENT, L.p. | Director | Dec 11 | Disposition to Issuer · D | −20,440,000 | — | — | 3,081,757 |
| Thomas Stephen Basil | Director | Aug 07 | Grant / award · A | +100,375 | — | — | 304,657 |
| Brennan Aoife | President and CEO | Jun 30 | Open-market sale · S | −20,618 | $1.22 | −$25.2K | 48,132 |
| Thomas Stephen Basil | Director | Jun 27 | Exercise / conversion · M | +25,094 | — | — | 204,282 |
| Brennan Aoife | President and CEO | Jun 27 | Exercise / conversion · M | +68,750 | — | — | 68,750 |
| Pimblett Emily | SVP, Finance & CAO | Jun 20 | Open-market sale · S | −1,242 | $1.24 | −$1.54K | 18,888 |
Loading...
